- Journal Archives
- Volume 19
- Volume 18
- Volume 17
- Volume 16
- Volume 15
- Volume 14
- Volume 13
- Volume 12
- Volume 11
- Volume 10
- Volume 9
- Volume 8
- Volume 7
- Volume 6
- Volume 5
- Volume 4
- Volume 3
- Volume 2
- Volume 1
- 2016-2017 Symposium
- 2015-2016 Symposium
- 2014-2015 Symposium
- 2013-2014 Symposium
- 2012-2013 Symposium
- 2011-2012 Symposium
- 2010-2011 Symposium
- 2009-2010 Symposium
- 2008-2009 Symposium
- 2007-2008 Symposium
Currently viewing the tag: "health care"
On November 3, 2015 By amontgomery November 2, 2015
On October 6, the Office of Inspector General issued a Policy Reminder entitled “Information Blocking and the Federal Anti-Kickback Statute.” The purpose of this reminder was to ensure the public understands how information blocking can affect safe harbor protection under the Federal anti-kickback statute (42 U.S.C. 1320a-7b(b)) and to encourage the public to report [...]Continue Reading →
On August 5, 2015 By Neil Issar August 3, 2015
Deep brain stimulation (DBS) is a neurosurgical procedure that has received FDA approval as a treatment for essential tremor, Parkinson’s disease, dystonia, and obsessive-compulsive disorder. The procedure involves an implanted pulse generator (IPG) connected by a thin steel wire to a lead with multiple cylindrical band electrode contacts at the distal end. The electrodes contact [...]Continue Reading →
Health insurers Premera Blue Cross and Anthem Inc. are the most recent victims of cyberattacks targeting healthcare entities to access the medical data and financial information of millions. Computer security software company, Websense Security Labs, predicted earlier that such cyberthefts would be on the rise in 2015. Websense claims security attacks on the [...]Continue Reading →
Patent Eligibility Symposium Wrap-Up
On Friday, Jan. 24, 2014, JETLaw hosted its 2013-2014 symposium, Patents 101: From Computer Code to Genetic Codes, focusing on what, exactly, is eligible for patent protection. Chief Judge Randall Rader of the Federal Circuit delivered the keynote address, and panels addressed software patents, gene patents, and principles of patent [...]Continue Reading →
Controversy has surrounded health care reform at least since the 2008 presidential elections, and it has not died down since President Obama signed the health care bill into law back in March. The Tea Party, perhaps the loudest opponent to this law, has consistently argued that Congress exceeded its constitutional power in passing the [...]Continue Reading →
Reminiscent of music industry tycoons, producers of “The Hurt Locker” sue BitTorrent users for illegal downloading of the film.
Gary McKinnon, computer hacker that breached Department of Defense and NASA websites, fights extradition to the United States.
Woman’s war against Adobe demonstrates the advantages of Continue Reading →
I respect the time, effort, and money that pharmaceutical companies devote to drug research and development, and advertising the drugs that are ultimately developed is an inevitable part of the research and development [...]Continue Reading →
In the news . . .
Ukrainian law prohibiting unmarried couples from adopting children bars Elton John and longtime partner David Furnish from adopting 14-month-old, HIV-stricken child.
PCs and iPhones with text-to-speech applications for speech-impaired denied coverage by Medicare and private health insurers due to other non-medical uses.Continue Reading →
Pfizer offered a major “mea culpa” last week when it agreed to pay $2.3 billion in fines for the “largest combined federal and state health care fraud settlement in the history of the Department of Justice.” The pharmaceutical company has ended up in this less than esteemed position as a result of its [...]Continue Reading →
Over the Counter but Under the Radar: Direct-to-Consumer Genetic Tests and FDA Regulation of Medical Devices
On May 6, 2009 By JETLaw May 6, 2009
Look for Over the Counter but Under the Radar: Direct-to-Consumer Genetic Tests and FDA Regulation of Medical Devices in the Spring 2009 issue (Vol. 11, No. 3) of the Vanderbilt Journal of Entertainment and Technology Law. The Abstract for the Note follows:
Direct-to-consumer genetic tests are laboratory-developed tests that are marketed and sold directly to consumers. [...]Continue Reading →
Recent Blog Posts
- The Cost of Being Free
- Will Trump’s Department of Justice Continue the 100% Licensing Fight?
- Court Software: A New Hurdle for the Legitimacy of the Criminal Justice System
- President Trump’s Executive Order and the Technology Community
- Recapping JETLaw’s 2017 Symposium!
- Meitu: fun new app or serious threat to your privacy?
Tagsadvertising antitrust Apple books career celebrities contracts copyright copyright infringement courts creative content criminal law entertainment Facebook FCC film/television financial First Amendment games Google government intellectual property internet JETLaw journalism lawsuits legislation media medicine Monday Morning JETLawg music NFL patents privacy progress publicity rights radio social networking sports Supreme Court of the United States (SCOTUS) technology telecommunications trademarks Twitter U.S. Constitution